abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 , R 2 , Z 1 , t and ring A are as defined in the specification. . The present invention also relates to pharmaceutical compositions comprising a compound of formula (I) and methods for treating conditions mediated by modulation of JNK, such as diabetes, which comprises an effective amount of a compound of formula (I) in a mammal. Administration. [Chemical 1] |